Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does ovarian follicle depletion accelerate in the mid-to-late 30s and lower AMH while raising early-follicular FSH?

Reproductive aging shows an accelerated loss of ovarian follicles around the mid-to-late 30s that lowers AMH and leads to elevated early-follicular FSH through reduced ovarian feedback and increased pituitary drive.

SupportedJune 19, 202620 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Ovarian follicle depletion accelerates with age in the mid-to-late 30s, which lowers AMH and can raise early-follicular FSH because reduced ovarian feedback increases pituitary drive.

laying out figure…
All 4 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that a marked inflection in follicle loss occurs in the mid-to-late 30s, producing a rapid decline in ovarian reserve and thus lower AMH levels. Mechanistically, fewer follicles reduce inhibitory signals (e.g., Inhibin B), removing negative feedback on the pituitary and increasing pituitary drive, which raises early-follicular FSH concentrations.

Verified conclusion

The biological process of reproductive aging is characterized by a predictable shift in the rate of ovarian reserve loss and the resulting hormonal feedback mechanisms.

Clinical evidence of follicle depletion

Research consistently identifies a non-linear decline in the ovarian follicle pool, with a significant inflection point occurring in the mid-to-late 30s.

  • Accelerated loss: Histological and statistical modeling, such as the Faddy-Gosden model, indicates that the rate of primordial follicle depletion shifts from a gradual decay to a rapid, exponential exhaustion around age 37.5.
  • Reserve metrics: By age 30, approximately 88% of the maximum pre-birth reserve is already depleted. By age 40, only about 3% of the initial reserve remains.
  • Biomarker correlation: Anti-Müllerian Hormone (AMH) serves as a direct proxy for this reserve. Because AMH is produced by the granulosa cells of preantral and small antral follicles, its concentration in the blood is intrinsically linked to the number of remaining follicles. Studies show a strong positive correlation (Pearson r = 0.40–0.66) between AMH levels and antral follicle count (AFC).

Mechanistic explanations

The elevation of early-follicular Follicle-Stimulating Hormone (FSH) is a compensatory response to this depletion, mediated by the hypothalamic-pituitary-ovarian (HPO) axis.

  • Reduced feedback: As the mass of granulosa cells in the ovary decreases due to follicle depletion, there is a significant drop in the production of Inhibin B. Inhibin B is the primary hormone responsible for suppressing FSH secretion from the pituitary gland.
  • Increased pituitary drive: The reduction in negative feedback from Inhibin B (and to a lesser extent, estradiol) removes the "brake" on the pituitary gland.
  • FSH elevation: In response to this lack of inhibition, the pituitary increases its drive, resulting in elevated FSH levels during the early follicular phase (typically days 2–3 of the cycle). Early-follicular FSH levels exceeding 10–15 IU/L are widely used clinical indicators of a diminished ovarian reserve.

Bottom line

The claim is strongly supported by biological and clinical evidence. Ovarian follicle depletion accelerates significantly around age 37, leading to lower AMH levels due to reduced follicle mass and elevated early-follicular FSH caused by the loss of inhibitory feedback on the pituitary gland.

References

  1. Ovarian follicle loss in humans and mice: lessons from statistical model comparison. — academic.oup.com ↗
  2. Cellular hallmarks of aging emerge in the ovary prior to primordial follicle depletion — pmc.ncbi.nlm.nih.gov ↗
  3. Reduced quality and accelerated follicle loss with female reproductive aging - does decline in theca dehydroepiandrosterone (DHEA) underlie the problem? — pmc.ncbi.nlm.nih.gov ↗
  4. Human ovarian reserve from conception to the menopause — arxiv.org ↗
  5. Anti-Müllerian hormone: biology and role in endocrinology and cancers — frontiersin.org ↗
  6. Anti-Müllerian hormone: biology and role in endocrinology and cancers — pmc.ncbi.nlm.nih.gov ↗
  7. Correlation of Anti-Mullerian Hormone with Antral Follicle Count among South Indian Infertile Women in a Tertiary Care Center — journals.lww.com ↗
  8. Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis — ovarianresearch.biomedcentral.com ↗
  9. Comparison between anti-Müllerian hormone and antral follicle count for assessment of ovarian reserve — ijrcog.org ↗
  10. Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively? — pmc.ncbi.nlm.nih.gov ↗
  11. Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively? — frontiersin.org ↗
  12. Ceruloplasmin and complement C3 are markers of diminished ovarian reserve in premenopausal women — fcm.kemsmu.ru ↗
  13. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. — pmc.ncbi.nlm.nih.gov ↗
  14. Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation — pmc.ncbi.nlm.nih.gov ↗
  15. Serum inhibins, estradiol, progesterone and FSH in surgical menopause: a demonstration of ovarian pituitary feedback loop in women. — academic.oup.com ↗
  16. Independent predictors and thresholds of in vitro fertilization outcomes in patients with diminished ovarian reserve — nature.com ↗
  17. Biomarkers of Ovarian Reserve — pmc.ncbi.nlm.nih.gov ↗
  18. Can Ovarian Reserve Assessment Predict Fertility following Breast Cancer Treatment? — journals.sagepub.com ↗
  19. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. — academic.oup.com ↗
  20. The Relationship Between Variation in Size of the Primordial Follicle Pool and Age at Natural Menopause. — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesCan obstructive sleep apnea lower testosterone in men?→Plausible5 sourcesDoes a non-elevated LH with low testosterone suggest secondary hypogonadism?→